الصفحة الرئيسية>>Analytical Standards>> Reference Materials>>APP-PICA

APP-PICA

رقم الكتالوجGC40916

PX 1 is a synthetic cannabinoid (CB) that is structurally analogous to AM2201, a potent CB receptor agonist.

Products are for research use only. Not for human use. We do not sell to patients.

APP-PICA التركيب الكيميائي

الحجم السعر المخزون الكميّة
1mg
111٫00
متوفر
5mg
258٫00
متوفر
50mg
1616٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PX 1 is a synthetic cannabinoid (CB) that is structurally analogous to AM2201 , a potent CB receptor agonist . [1]  APP-PICA is an analog of PX 1 that lacks the alkyl-terminal fluorine atom. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Reference:
[1]. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives. PCT/US00/28832, (2001).

مراجعات

Review for APP-PICA

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for APP-PICA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.